JP2023501308A5 - - Google Patents
Info
- Publication number
- JP2023501308A5 JP2023501308A5 JP2022525870A JP2022525870A JP2023501308A5 JP 2023501308 A5 JP2023501308 A5 JP 2023501308A5 JP 2022525870 A JP2022525870 A JP 2022525870A JP 2022525870 A JP2022525870 A JP 2022525870A JP 2023501308 A5 JP2023501308 A5 JP 2023501308A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2019904097 | 2019-10-30 | ||
| AU2019904097A AU2019904097A0 (en) | 2019-10-30 | Anti-mullerian hormone polypeptides | |
| PCT/AU2020/051187 WO2021081601A1 (en) | 2019-10-30 | 2020-10-30 | Anti-mullerian hormone polypeptides |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023501308A JP2023501308A (ja) | 2023-01-18 |
| JPWO2021081601A5 JPWO2021081601A5 (https=) | 2023-11-09 |
| JP2023501308A5 true JP2023501308A5 (https=) | 2023-11-09 |
Family
ID=75714709
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022525870A Pending JP2023501308A (ja) | 2019-10-30 | 2020-10-30 | 抗ミュラー管ホルモンポリペプチド |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20220411477A1 (https=) |
| EP (1) | EP4051699A4 (https=) |
| JP (1) | JP2023501308A (https=) |
| KR (1) | KR20220155980A (https=) |
| CN (1) | CN114945588A (https=) |
| AU (1) | AU2020373165A1 (https=) |
| CA (1) | CA3156607A1 (https=) |
| WO (1) | WO2021081601A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025049960A1 (en) * | 2023-08-30 | 2025-03-06 | University Of Cincinnati | Enhancing the production of anti-mullerian hormone through modification of its prodomain |
| WO2025085972A1 (en) * | 2023-10-27 | 2025-05-01 | Monash University | Anti-mullerian hormone agonists |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009012357A2 (en) * | 2007-07-17 | 2009-01-22 | The General Hospital Corporation | Methods to identify and enrich for populations of ovarian cancer stem cells and somatic ovarian stem cells and uses thereof |
| WO2010017290A1 (en) * | 2008-08-05 | 2010-02-11 | The Trustees Of Columbia University In The City Of New York | Müllerian inhibiting substance (mis) analogues |
| CA2837472A1 (en) * | 2011-05-27 | 2012-12-06 | Fox Chase Cancer Center | Rationally-designed anti-mullerian inhibiting substance type ii receptor antibodies |
| AU2013342190B2 (en) * | 2012-11-09 | 2018-11-08 | Ansh Labs Llc | Antibody compositions and immunoassay methods to detect isoforms of Anti-Mullerian Hormone |
| US11230583B2 (en) * | 2015-11-26 | 2022-01-25 | Hudson Institute of Medical Research | Inhibin analogs |
| EP3257867A1 (fr) * | 2016-06-17 | 2017-12-20 | Biomérieux | Procédé de préparation d'anticorps anti-amh et leurs utilisations |
| WO2018112168A1 (en) * | 2016-12-14 | 2018-06-21 | The General Hospital Corporation | Mullerian inhibiting substance (mis) proteins for ovarian and uterine oncoprotection, and ovarian reserve and uterine preservation |
| US11261225B2 (en) * | 2017-02-10 | 2022-03-01 | Institute For Cancer Research | Chimera of bone morphogenic protein 2 and the Müllerian-inhibiting substance type II receptor binding region of Müllerian-inhibiting substance |
-
2020
- 2020-10-30 JP JP2022525870A patent/JP2023501308A/ja active Pending
- 2020-10-30 CA CA3156607A patent/CA3156607A1/en active Pending
- 2020-10-30 EP EP20880602.6A patent/EP4051699A4/en active Pending
- 2020-10-30 AU AU2020373165A patent/AU2020373165A1/en not_active Abandoned
- 2020-10-30 CN CN202080090934.2A patent/CN114945588A/zh active Pending
- 2020-10-30 KR KR1020227018295A patent/KR20220155980A/ko not_active Ceased
- 2020-10-30 WO PCT/AU2020/051187 patent/WO2021081601A1/en not_active Ceased
- 2020-10-30 US US17/773,529 patent/US20220411477A1/en not_active Abandoned